Systematic review with meta-analysis: Faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies

Alimentary Pharmacology and Therapeutics

Volumn 43, Issue 7, 2016, Pages 755-764

  Hirai, H W ^a,b   Tsoi, K K F ^a,b   Chan, J Y C ^a   Wong, S H ^b   Ching, J Y L ^b   Wong, M C S ^a,b   Wu, J C Y ^b   Chan, F K L ^b   Sung, J J Y ^b   Ng, S C ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; IMMUNOCHEMISTRY; META ANALYSIS; OCCULT BLOOD TEST; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; AGED; BLOOD; COHORT ANALYSIS; COLON; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; MALE; MIDDLE AGED; OCCULT BLOOD; PATHOLOGY; PROCEDURES; STANDARDS;

GUAIAC;

AGED; COHORT STUDIES; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GUAIAC; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD;

EID: 84959560588     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13556     Document Type: Review

References (45)

1. Siegel R, Ma J, Zou Z, Jemal A,. Cancer Statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Sung JJ, Ng SC, Chan FK, et al,. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015; 64: 121-32.
3. Mandel JS, Church TR, Bond JH, et al,. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
4. Mandel JS, Bond JK, Church TR, et al,. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
5. Feinberg EJ, Steinberg WM, Banks BL, Henry JP,. How long to abstain from eating red meat before fecal occult blood tests. Ann Intern Med 1990; 113: 403-4.
6. Songster CL, Barrows GH, Jarrett DD,. Immunochemical detection of fecal occult blood. The fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer 1980; 45: 1099-102.
7. Brenner H, Tao S,. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013; 49: 3049-54.
8. Park DI, Ryu S, Kim YH, et al,. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010; 105: 2017-25.
9. Parra-Blanco A, Gimeno-Garcbox drawings light down and left′a AZ, Quintero E, et al,. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010; 45: 703-12.
10. Tao S, Brenner H,. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening. Eur J Cancer Prev 2013; 22: 305-10.
11. Allison JE, Tekawa IR, Tansom LH, Adrain AL,. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155-16.
12. Castiglione G, Zappa M, Grazzini G, et al,. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 1996; 74: 141-4.
13. Frommer DJ, Kapparis A, Brown MK,. Improved screening for colorectal cancer by immunological detection of occult blood. BMJ 1988; 296: 1092-4.
14. Robinson MH, Marks CG, Farrands PA, Thomas WM, Hardcastle JD,. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surgery 1994; 81: 448-51.
15. Lee JK, Liles EG, Bent S, Levin TR, Corley DA,. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014; 160: 171-81.
16. Launois R, Le Moine JG, Uzzan B, Fiestas Navarrete LI, Benamouzig R,. Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. Eur J Gastroenterol Hepatol 2014; 26: 978-89.
17. Rosman AS, Korsten MA,. Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis. J Gen Intern Med 2010; 25: 1211-21.
18. Oono Y, Iriguchi Y, Doi Y, et al,. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Clin Chim Acta 2010; 411: 802-5.
19. Young GP, St John DJB, Cole SR, et al,. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screen 2003; 10: 123-8.
20. Kutzner N, Hoffmann I, Linke C, et al,. Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Lett 2005; 229: 33-41.
21. St. John DJB, Young GP, Mchutchison JG, et al,. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann Intern Med 1992; 117: 376-82.
22. Moher D, Liberati A, Tetzlaff J, Altman DG,; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-9.
23. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM,; Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008; 149: 889-97.
24. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y,. Chapter 10: analysing and Presenting Results. In:, Deeks JJ, Bossuyt PM, Gatsonis C, eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available at: http://srdta.cochrane.org/.
25. Whiting PF, Rutjes AW, Westwood ME, et al,.; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-36.
26. Bossuyt PM, Reitsma JB, Bruns DE, et al,. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138: W1-12.
27. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH,. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J ClinEpidemiol 2005; 58: 982-90.
28. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM,. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35.
29. Rutter CM, Gatsonis CA,. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001; 20: 2865-84.
30. Swets JA,. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285-93.
31. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
32. Bjerregaard NC, Tottrup A, Sorensen HT, Laurberg S,. Detection of colorectal cancer in symptomatic outpatients without visible rectal bleeding: validity of the fecal occult blood test. Clin Epidemiol 2009; 1: 119-24.
33. Chiu HM, Lee YC, Tu CH, et al,. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol 2013; 11: 832-8.
34. Hope RL, Chu G, Hope AH, Newcombe RG, Gillespie PE, Williams SJ,. Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut 1996; 39: 722-5.
35. Kaul A, Shah A, Magill FH, et al,. Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients. Int J Surg 2013; 11: 329-31.
36. Kim BC, Joo J, Chang HJ, et al,. A predicitive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer. PLoS ONE 2014; 9: e106182.
37. Koga Y, Yamazaki N, Yamamoto Y, et al,. Fecal miR-106a Is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2013; 22: 1844-52.
38. Lee Y, Chiu H, Chiang T, et al,. Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions. BMJ Open 2013; 3: e003989.
39. Shastri YM, Loitsch S, Hoepffner N, et al,. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study. Am J Gastroenterol 2008; 103: 1496-504.
40. Sung JJ, Chan FK, Leung WK, et al,. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 2003; 124: 608-14.
41. Thomas WM, Hardcastle JD, Jackson J, Pye G,. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients. Br J Cancer 1992; 65: 618-20.
42. Chiu HM, Lee YC, Tu CH, et al,. Association between early stage colon neoplasms and false-negative results from the decal immunochemical test. Clin Gastroenterol Hepatol 2013; 11 (7): 832-8. e2
43. van Rossum LGM, van Rijn AF, van Oijen MGH, et al,. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009; 125: 746-50.
44. Nelson RL, Dollear T, Freels S, Persky V,. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997; 80: 193-7.
45. Daly JM, Bay CP, Levy BT,. Evaluation of fecal immunochemical tests for CRC screening. J Prim Care Com Health 2013; 4: 245-50.